Advertisement Article continues below this ad Wegovy and Zepbound are part of a GLP-1 class of treatments that has shown unprecedented results for helping people shed weight by decreasing appetite and ...

It's the second year in a row that Lilly has used the Oscars as a platform to drive home a message about GLP-1-based obesity therapies, having aired an ad in 2024 that urged people not to use them for ...

Eli Lilly lowered Zepbound’s starter dose to $349 per month The lower prices are available for uninsured patients and folks ...

INDIANAPOLIS — Eli Lilly announced Wednesday the launch of higher doses of Zepbound — and that the company is lowering the price of certain doses. People taking Zepbound, or interested in starting, ...

Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its latest attempt to fend off competition from copies of its weight-loss drug.

While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...

Singer Michael Trotter Jr of The War and Treaty, chef Franklin Becker of “Top Chef Masters,” and a beauty salon owner ...

Zepbound is available for on-label self-pay ... admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. How we use your information ...

Certain companies seem particularly relentless. Their ads don’t explicitly name the drugs they prescribe, but they don’t need to. Suggestive phrases like “doctor-supported weight loss” and “clinically ...

Copycat drugs can save consumers money in the short term. But the societal cost of the signals this sends to the pharmaceutical industry could be devastating. It will surely cause delays and defunding ...

Sleep-deprived night shift nurses are at greater risk for the common cold and other infectious diseases, a new study says.